Actively Recruiting
Comparing 11CMetomidate PET-CT and Adrenal Venous Sampling for Diagnosing Primary Aldosteronism A Randomized Proof-of-Concept Study
Led by Chinese University of Hong Kong · Updated on 2026-10-26
32
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are comparing two methods to identify the source of excess aldosterone hormone production in people diagnosed with primary aldosteronism PA. This randomized, open-label controlled study focuses on evaluating the biochemical and clinical responses between 11CMetomidate PET-CT MTO-PET and the usual care method of adrenal venous sampling AVS. The main goal is to determine the proportion of participants achieving complete or partial clinical success after treatment for PA. Participants are randomly assigned to one of two groups one receives 11CMetomidate PET-CT as the first imaging procedure to locate adrenal abnormalities, and the other undergoes adrenal venous sampling as per the usual care standard. 11CMetomidate acts as a radiotracer in PET-CT scans to detect specific enzyme activity in the adrenal cortex. Adrenal venous sampling involves catheter insertion to sample hormone levels from each adrenal vein. Both procedures help guide treatment decisions. During the study, participants will be monitored over 6 and 12 months to assess clinical outcomes related to PA treatment. Researchers will measure the proportion of participants who achieve complete or partial clinical success based on biochemical and clinical evaluations. The trial involves regular assessments and follow-up to gather this data, with the overall study planned to complete by September 2030.
CONDITIONS
Brief Title
[11C]Metomidate PET-CT vs Usual Care for People With Primary Aldosteronism: a Proof-of-concept Study
Research Team
E
Edith WK Chow, MBChB
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here